Technical Analysis for NK - NantKwest, Inc.

Grade Last Price % Change Price Change
grade C 1.26 -5.97% -0.08
NK closed down 5.97 percent on Friday, March 22, 2019, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical NK trend table...

Date Alert Name Type % Chg
Mar 22 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Mar 22 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 22 Upper Bollinger Band Walk Strength 0.00%
Mar 22 Upper Bollinger Band Touch Strength 0.00%
Mar 21 Boomer Buy Setup Bullish Swing Setup -5.97%
Mar 21 Upper Bollinger Band Walk Strength -5.97%
Mar 21 Above Upper BB Strength -5.97%
Mar 21 Upper Bollinger Band Touch Strength -5.97%
Mar 20 Upper Bollinger Band Walk Strength -4.55%
Mar 20 Inside Day Range Contraction -4.55%

Older signals for NK ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
NantKwest, Inc., a biotechnology company, develops immunotherapeutic agents for various clinical conditions. It is initiating a Phase II clinical trial for its activated natural killer product candidate for the treatment of virally-induced cancers, such as polyomavirus induced Merkel cell carcinoma, human Papillomavirus, induced cervical cancer, and head and neck cancer, as well as infectious diseases comprising Ebola and other viral, fungal, and bacterial infections. The company also holds right to commercialize a range of genetically modified derivatives that kills cancer and virally infected cells. In addition, it focuses on to initiate a Phase I/II clinical trials for target activated natural killer product candidate for acute myeloid leukemia and bulky hematological cancers. The company was formerly known as Conkwest, Inc. and changed its name to NantKwest, Inc. in July 2015. NantKwest, Inc. was founded in 2002 and is headquartered in Cardiff-by-the-Sea, California.
Biotechnology Cancer Infectious Diseases Acute Myeloid Leukemia Bacterial Infections Infectious Causes Of Cancer Head And Neck Cancer Virus Human Papillomavirus Infection Carcinogenesis Cervical Cancer Ebola Merkel Cell Carcinoma Papillomavirus
Is NK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.4
52 Week Low 0.93
Average Volume 282,617
200-Day Moving Average 2.3435
50-Day Moving Average 1.2062
20-Day Moving Average 1.218
10-Day Moving Average 1.247
Average True Range 0.1227
ADX 41.91
+DI 30.3829
-DI 9.6252
Chandelier Exit (Long, 3 ATRs ) 1.2919
Chandelier Exit (Short, 3 ATRs ) 1.4581
Upper Bollinger Band 1.3444
Lower Bollinger Band 1.0916
Percent B (%b) 0.67
BandWidth 20.755337
MACD Line 0.0258
MACD Signal Line 0.0115
MACD Histogram 0.0143
Fundamentals Value
Market Cap 100.09 Million
Num Shares 79.4 Million
EPS -1.29
Price-to-Earnings (P/E) Ratio -0.98
Price-to-Sales 7227.62
Price-to-Book 1.46
PEG Ratio 2.18
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.46
Resistance 3 (R3) 1.47 1.43 1.42
Resistance 2 (R2) 1.43 1.38 1.42 1.41
Resistance 1 (R1) 1.34 1.35 1.32 1.33 1.40
Pivot Point 1.30 1.30 1.29 1.29 1.30
Support 1 (S1) 1.21 1.25 1.19 1.20 1.12
Support 2 (S2) 1.17 1.22 1.16 1.11
Support 3 (S3) 1.08 1.17 1.10
Support 4 (S4) 1.07